BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11005253)

  • 1. Biological and clinical review of stromal tumors in the gastrointestinal tract.
    Nishida T; Hirota S
    Histol Histopathol; 2000 Oct; 15(4):1293-301. PubMed ID: 11005253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.
    Miettinen M; Lasota J
    Virchows Arch; 2001 Jan; 438(1):1-12. PubMed ID: 11213830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors: recent advances in understanding of their biology.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Hum Pathol; 1999 Oct; 30(10):1213-20. PubMed ID: 10534170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
    Yasuoka R; Sakakura C; Shimomura K; Fujita Y; Nakanishi M; Aragane H; Hagiwara A; Bamba M; Abe T; Yamagishi H
    Dig Surg; 2003; 20(3):183-91. PubMed ID: 12759497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumors: their origin and cause.
    Hirota S
    Int J Clin Oncol; 2001 Feb; 6(1):1-5. PubMed ID: 11706520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
    Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M
    Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumours.
    Miettinen M; Sarlomo-Rikala M; Lasota J
    Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin.
    Lasota J; Kopczynski J; Sarlomo-Rikala M; Schneider-Stock R; Stachura T; Kordek R; Michal M; Boltze C; Roessner A; Stachura J; Miettinen M
    Hum Pathol; 2003 Dec; 34(12):1306-12. PubMed ID: 14691917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
    Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
    Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal mesenchymal tumors: a clinical pathologic and immunohistochemical study of 210 cases].
    Wang ZQ; Wang S; Ye YJ; Kang YL; Sun KK; Zheng HF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):11-6. PubMed ID: 17253165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.
    Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S
    Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal stromal tumors.
    Strickland L; Letson GD; Muro-Cacho CA
    Cancer Control; 2001; 8(3):252-61. PubMed ID: 11378651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
    Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.